Roflumilast Prescribing at SPRING-FENISCO HEALTHLINK
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
19
Total Quantity
587
NHS Cost
£701
vs National Avg
+44.7%
SPRING-FENISCO HEALTHLINK prescribed 19 items of Roflumilast over the last 12 months at a cost of £701 to the NHS. This is 44.7% above the national average prescribing rate. Roflumilast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 19 |
|---|---|
| Total Quantity | 587 |
| Total NHS Cost | £701 |
| Presentations | 2 different forms |
| vs National Average | +44.7% |
Roflumilast Prescribing Comparison
| This practice | 19 items |
|---|---|
| National average per practice | 13 items |
| Difference | +44.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.